Evolution Wealth Advisors, LLC Dexcom Inc Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$129.87 - $162.82 $12,727 - $15,956	-98 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $1,173 - $1,574	-11 Reduced 10.09%	98 $54,000
Q2 2021 Jul 22, 2021	BUY	$80.99 - $107.93 $2,105 - $2,806	26 Added 31.33%	109 $47,000
Q1 2021 Apr 20, 2021	BUY	$84.79 - $104.74 $2,458 - $3,037	29 Added 53.7%	83 $30,000
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $1,794 - $2,403	23 Added 74.19%	54 $20,000
Q2 2020 Jul 27, 2020	SELL	$62.68 - $105.34 $1,253 - $2,106	-20 Reduced 39.22%	31 $13,000
Q1 2020 Apr 22, 2020	SELL	$47.79 - $75.63 $286 - $453	-6 Reduced 10.53%	51 $14,000
Q4 2019 Feb 03, 2020	SELL	$36.62 - $57.29 $585 - $916	-16 Reduced 21.92%	57 $12,000
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $319 - $394	-9 Reduced 10.98%	73 $11,000
Q2 2019 Jul 12, 2019	BUY	$27.84 - $38.92 $2,282 - $3,191	82 New	82 $12,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.